Asthma and asthma-like disorders  by Löwhagen, O.
RESPIRATORY MEDICINE (1999) 93, 851-855 
Asthma and asthma-like disorders 
0. L~WHAGEN 
Allergy Centre, Sahlgrenska University Hospital, Gsteborg, Sweden 
Bronchial asthma is defined as a chronic inflammatory disease resulting in a reversible and variable bronchial 
obstruction. For the clinical diagnosis of the disease there are some key indicators but as there is no ‘gold standard’ 
a correct diagnosis will sometimes not be obtained. Examples are patients in a symptom-free stage, current 
medication interfering with the methods used, patients with asthma-like symptoms reporting lack of effect of 
bronchodilators and patients who are unable to perform a forced expiration in an airway function test. The 
prevalence of asthma is reported to be 5-10%. The prevalence of asthma-like symptoms may be double this. 
The term ‘asthma-like’ has been used to an increasing extent during the last few years, which may indicate an 
increasing awareness of the fact that asthma-like symptoms are not always classical asthma. In this overview some 
disorders with asthma-like symptoms, especially in adults, are presented. The spectrum of differential diagnoses in a 
clinic may depend on which doctor/specialist the patient is consulting. In an asthma and allergy clinic it has been 
found that the most common differential diagnoses are chronic obstructive pulmonary disease (COPD), non- 
asthmatic cough and sensory hyper-reactivity (SHR), a disorder which is sometimes mixed up with asthma due to 
similar symptoms (heavy breathing, cough, increased secretion, difficulty in getting air etc.) and similar trigger 
factors (smoke, strong scents, exercise, cold air etc.). Recently it has been suggested that a capsaicin inhalation test 
may be an objective test for identifying patients with SHR. In asthma effective treatment is available today but in 
asthma-like disorders, such as SHR, no effective therapy is available, underlining the need of further research for 
understanding the pathophysiological mechanisms. 
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Introduction 
Bronchial asthma is a well-known disease, in international 
consensus reports (14) defined as a chronic inflammatory 
disease, in which eosinophils, mast cells and other cells and 
cellular elements play an important role. The inflammation 
causes airway hyper-responsiveness and is the reason for 
the appearance of variable and reversible airflow obstruc- 
tion. However, although the role of inflammation is stressed 
there is still no easily available method for assessing the 
type and degree of airway inflammation (5). Methods 
aimed at reflecting airway inflammation such as assess- 
ments of cells and cell elements in induced sputum (68), 
inflammatory markers in the blood (9) and markers in 
exhaled air (10,l l), have not yet been widely used. 
There is also no ‘gold standard’ for the definition of 
clinical asthma but some key indicators are diagnostic (4). 
Major key indicators are an increase in forced expiratory 
volume in 1 set (FEVi)>12% or 2200 ml after a 
bronchodilator, diurnal variation in peak expiratory flow 
(PEF) 220 % and a positive methacholine or histamine 
test. No single test is diagnostic and exclusion of other 
possible diagnoses is always needed. Furthermore, there are 
no airway symptoms that may, with certainty, be associated 
with asthma although wheezing, particularly in the early 
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morning and after exposure to cold air and exercise, is a 
strong indicator. There is also a relatively weak correlation 
between the different diagnostic tests (12). The consequence 
is that the clinical diagnosis is dependent on what 
symptoms, diagnostic methods and normal limits have 
been selected. 
Although it has been emphasized that making the correct 
diagnosis of asthma is extremely important (1,4), little 
attention has been paid to the fact that this is associated with 
considerable difficulty in many cases. Examples are patients 
with atypical airway symptoms, patients in a symptom-free 
stage, current medication interfering with the methods used, 
patients with asthma-like symptoms reporting lack of effect 
of bronchodilators, different responses in different asthma 
tests, no or slight response to oral steroid burst and patients 
who are unable to perform a forced expiration in airway 
function and methacholine tests. Treatment with anti- 
asthmatic drugs such as corticosteroids and &agonists is a 
special problem, as these drugs may reduce or normalize 
diagnostic variables, such as symptoms, reversibility, varia- 
bility and bronchial hyper-reactivity. The influence of 
asthma medication stresses the importance of making the 
diagnostic work, including adequate spirometry, before any 
medication is introduced. 
The intensity of differential diagnostic work is dependent 
on the need for demarcation of other adjacent disorders. 
Such a separation and identification is an important issue, 
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TABLE 1. Disorders including asthma-like symptoms 
Chronic obstructive pulmonary disease (COPD) 
Chronic bronchitis due to smoking 
Chronic cough for other reasons 
Hyperventilation 
Mechanical obstruction of the airways 
Congestive heart failure 
Pulmonary embolism 
Gastro-oesophageal reflux (GER) 
Multiple chemical sensitivity (MCS)/idiopathic 
environmental illness (IEI) 
Reactive airway dysfunction syndrome @ADS) 
Sick building syndrome (SBS) 
Vocal cord dysfunction 
Sjogren’s syndrome 
Functional respiratory disorder/sensory hyper-reactivity 
as patients presenting asthma-like symptoms may report 
symptoms as well as physical and social handicaps as severe 
as patients with classical asthma (13,14). Asthma is a 
respiratory disease that has been much in focus during the 
last few years. The consequence of this may be that other 
common but less well-known disorders are not sufficiently 
considered. The prevalence of asthma in several countries is 
found to be 5-lo%, but the prevalence of asthma-like 
symptoms may be double this. Breathing troubles induced 
by trigger factors such as cold air, exercise and chemical 
irritants were present in 15-20% in an epidemiological 
study (to be published) and bronchial inflammation in 
biopsies not typical for asthma was found in about 10 % of 
the population (15). For these changes the term asthma-like 
inflammation has been suggested (15). 
Asthma-like 
The term ‘asthma-like’ has been used to an increasing 
extent during the last few years, which may indicate an 
increasing awareness of the fact that asthma-like symptoms 
are not always associated with asthma (reversible bronchial 
obstruction). In this overview a selected number of 
disorders that may be mixed up with asthma are presented. 
Of course, only disorders with given names are mentioned, 
there may be more, not yet identified. The presentation 
focuses on the differential diagnoses of asthma in adults, 
but asthma-like disorders have also been observed in 
children (14,16). Disorders including asthma-like symptoms 
are shown in Table 1. 
Chronic obstructive pulmonary 
disease 
One of the most common differential diagnoses of asthma is 
chronic obstructive pulmonary disease (COPD), often 
preceded by chronic bronchitis. The disease is characterized 
by a slowly progressive reduction of the pulmonary 
ventilation due to a combination of emphysema and 
bronchiolitis with obstruction of the small airways. The 
most important aetiological factor is tobacco smoking. The 
first symptom is usually an exercise-induced breathing 
complaint. COPD is distinguished from asthma by demon- 
stration that the bronchial obstruction is not, or only 
slightly, reversible to steroids and bronchodilators. 
Chronic cough 
Cough, not due to smoking, with or without other asthma- 
like symptoms may have several different aetiologies, for 
example asthma, gastric-oesophageal reflux, post-nasal 
drip, pertussis, acetyl cholinesterase (ACE) inhibitor 
therapy and sensory hyper-reactivity (17) but in some 
cases cough is a single symptom not induced by any known 
trigger factor. Cough at night and cough associated with 
physical exercise may be indications of asthma. For the 
diagnosis of asthma tests such as reversibility to a 
bronchodilator, methacholine/histamine test and increased 
levels of exhaled nitric oxide (18) have to be positive. Reflex 
bronchoconstriction and cough may be induced by different 
sensory pathways (19). 
Hyperventilation syndrome 
The hyperventilation syndrome has been defined as a 
syndrome characterized by a variety of somatic symptoms 
induced by physiologically inappropriate hyperventilation 
and usually reproduced in whole or in part by voluntary 
hyperventilation (20). The symptoms are thought to be due 
to hyperventilation with subsequent hypocapnt. Some of 
these, such as shortness of breath, accelerated/deepened 
breathing and feeling unable to breathe deeply are asthma- 
like with the risk that this condition is mixed up with 
asthma (21). Hyperventilation may also induce a bronchial 
constriction in susceptible individuals. For establishing the 
diagnosis two criteria have been proposed, symptoms 
reproduced by a hyperventilation test (22) and a slow 
recovery of CO;! in blood or expired air after a hyperventi- 
lation test (21,22). The diagnostic criteria and the definition 
of the syndrome, however, are a matter of debate (23). One 
major problem is that many patients reporting acute airway 
symptoms associated with hyperventilation do not show 
any lowering of end-tidal COZ. Another problem is that the 
specificity and sensitivity of the hyperventilation test are 
not high (24), indicating that the hyperventilation syn- 
drome is not a well-defined clinical entity. It is more likely 
that hyperventilation, like cough, should only be considered 
as a symptom with different aetiological origins. 
Reactive airway dysfunction 
syndrome (RADS) 
RADS, the term coined in 1985, is an illness with asthma- 
like symptoms developing as the direct consequence of 
massive toxic inhalation exposure (25). The bronchial 
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histological changes show an increase of inflammatory cells 
although eosinophils and mast cells do not dominate. Not 
all experts are certain that this syndrome is a distinct 
clinical entity. 
Multiple chemical sensitivity/ 
idiopathic environmental intolerance 
Multiple chemical sensitivity (MCS), also called idiopathic 
environmental illness (IEI), (26) is defined as a disease 
acquired in relation to some environmental exposure 
leading to symptoms in more than one organ. The 
symptoms occur in response to chemical compounds at 
doses below those known to cause harmful effects in the 
general population. However, the disorder has not been 
well defined and there is not yet any objective test that can 
identify patients with this disorder (27). Common symp- 
toms are headache, weakness, memory problems, inability 
to concentrate, throat soreness, abdominal pain and 
discomfort. In the airways the patients may suffer from 
nasal congestion and asthma-like symptoms such as cough 
and chest tightness. A number of theories have been put 
forward to address the cause of MCS/IEI and the 
mechanism by which diverse environmental exposures 
produce symptoms. Most studies to date have found an 
excess of current and past psychopathology. Controlled 
studies to verify the patient’s reported increased sensitivity 
to specific environmental chemicals have to be carried out. 
Sick building syndrome (SBS) 
Sick building syndrome is a complex disease of skin and 
mucous membrane irritation caused mainly by inadequate 
air-handling systems in energy efficient buildings (28). The 
most common symptoms are dry skin in the face, irritation 
of the eyes and some airway symptoms like rhinitis, dry 
throat, hoarseness and cough (29). Unlike MCS/IEI these 
patients experience a limited range of symptoms associated 
with the affected building only. 
S jogren’s syndrome 
Sjogren’s syndrome is a common systemic rheumatic 
disease. Pulmonary disease is prevalent including asthma- 
like symptoms like chronic cough and bronchial obstruc- 
tion (30). Other manifestations are pulmonary lymphoma 
and interstitial lung disease. 
Vocal cord dysfunction 
Vocal cord dysfunction is characterized by episodic or acute 
attacks of breathing troubles similar to attacks of asthma. 
It is distinguished from asthma by the absence of ronchi 
over basal-dorsal lung areas and the presence of stridor 
over the larynx as well as visible abnormality of the vocal 
cords at inspection (31). Clinically, the effect of broncho- 
dilators is slight or none. 
‘Ski asthma’ 
In elite cross-country skiers, asthma, asthma-like symptoms 
and bronchial hyper-responsiveness are more common 
compared to non-skiers and the general population (32). 
Strenuous exercise in cold air may be the most probable 
explanation for this disorder. The disorder has been called 
‘ski asthma’, although typical asthmatic bronchial inflam- 
mation, such as increased counts of neutrophil and 
eosinophil cells and increased level of eosinophil cationic 
protein have not been detected. Biopsy sections from the 
bronchi have shown inflammation with aggregates of 
lymphoid cells (33) and after exposure to cold air an 
increase of the number of granulocytes and macrophages in 
the lower airways has been reported (34). 
Sensory hyper-reactivity 
A differential diagnosis of asthma called sensory hyperreac- 
tivity has recently been described (17). The disorder, earlier 
called functional breathing disorder (13,35), is a syndrome 
that has frequently been found among patients referred to a 
specialist clinic for investigation of suspected asthma (36). 
The clinical research was inspired by the fact that asthma in 
many cases was, and still is, mixed up with this asthma-like 
syndrome (37,38). The characteristics are airway symptoms 
and trigger factors known from the asthma literature, but in 
these cases not directly associated with reversible and 
variable bronchial obstruction (13,35,36,39,40). Further- 
more, spirometry is sometimes difficult to obtain due to 
inability to perform an adequate forced expiration, which 
may incorrectly be interpreted as an indication of bronch- 
oconstriction. The most common symptoms are heavy 
breathing, cough, increased secretion, difficulty in getting 
air and chest pressure/load (35,38). The symptoms are often 
induced by a trigger factor, the most common being irritants, 
such as smoke and strong scents, and physical exercise. Some 
symptoms earlier reported to indicate asthma, such as 
difficulty in breathing and breathlessness (4) may more 
likely be indicators of sensory hyper-reactivity. The symp- 
toms are in some cases more dramatic than those of asthma 
and, unless critically examined and properly investigated 
with spirometry, the symptoms may be interpreted as severe 
asthma. This is of special importance as asthma and asthma- 
like symptoms may be present in the same individual. 
In a recent re-evaluation of the diagnosis of asthma it was 
shown that the diagnosis could be verified in only two thirds 
of the patients (41), the most common diagnoses in non- 
verified cases being COPD and functional breathing disorder 
with symptoms seen in patients with sensory hyper-reactivity. 
Some of the asthma-like symptoms presented may be induced 
by hyperventilation (21) and the question is whether or not 
functional breathing disorder and sensory hyper-reactivity is 
part of the hyperventilation syndrome. However, in most 
patients with a sensory hyper-reactivity no changes in 
854 0. L~WHAGEN 
endtidal-CO2 at rest can be demonstrated and only a few 
patients react with a reduction of endtidal-CO2 during 
exercise and provocation to perfume and capsaicin. Hyper- 
ventilation may therefore be considered as one of several 
asthma-like symptoms. The reported asthma-like disorder 
may be recognized by the pattern of symptoms in the absence 
of reversible bronchial obstruction and other known airway 
disease. In some patients non-respiratory symptoms, such as 
eye irritation, chest pain and tiredness have also been 
observed. However, the diagnosis of sensory hyper-reactivity 
has so far been limited to patients with asthma-like symptoms 
as mixing of asthma and asthma-like disorders is a clinical 
problem today. To identify sensory hyper-reactivity is 
possible in the majority of the patients referred for suspected 
asthma, but it needs experience and carefully performed 
airway function tests. Recently it has been shown that a 
capsaicin inhalation test can provoke these kinds of 
symptoms (17), suggesting that this test may be useful for 
objective identifcation of these patients. Capsaicin is a specific 
stimulus of sensory nerves and has earlier been used for 
assessing the tendency to cough (42). Our present theory is 
that asthma-like symptoms are provoked by a sensory nerve- 
mediated disturbance of the respiratory pattern. Studies 
aimed to ‘block this kind of hyper-reactivity are in progress. 
Trigger factors 
Trigger factors are of special interest in differential diagnoses 
of asthma. The most generally reported trigger factors in 
asthma inducing acute breathing troubles are allergens, 
physical exercise; cold air, chemical irritants, mental stress, 
aspirin and respiratory viral infections. When symptom 
scores from chemical triggers, such as smoke, exhaust fumes 
and perfumes, are correlated with the response to methacho- 
line, no correlation was found indicating different mechan- 
isms of action. Only the symptom score from exercise and 
cold air were significantly correlated to the methacholine test 
(unpublished data). Furthermore, when symptom scores 
from strong scents were correlated with a methacholine test 
no significant correlations were found indicating that the 
methacholine test cannot be used for revealing an increased 
sensitivity to strong scents (43). 
Treatment and management 
For asthma effective medication is available, but in some 
cases of asthma-like disorders, particularly sensory hyper- 
reactivity, there is no effective medication. However, the 
majority of patients with an asthma-like disorder referred 
for investigation of suspected asthma have been prescribed 
some kind of asthma medication. It has also been observed 
that treatment compliance in asthma is low (44,45). One of 
the reasons may be lack of subjective effect. This may be 
interpreted as poor compliance in cases where a new 
evaluation may show that the diagnosis was not correct. An 
asthma-like disorder must always be considered in patients 
resistant to conventional therapy (37), particularly in 
steroid-insensitive asthma (46) as steroids are the most 
potent drugs in the treatment of asthma, and as up to 25 % 
of all patients with reported severe asthma may be steroid- 
insensitive (46). Because the clinical and social severity of 
the disease may be similar or worse in patients with asthma- 
like symptoms (13,14), it is of fundamental importance to 
identify and describe these disorders. This is a matter for 
research, especially initial clinical research, as symptoms 
and signs are difficult to study in the laboratory. 
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